Transient deficiency of protein S after past infection process, complications and outcome: clinical case
https://doi.org/10.15690/pf.v20i1.2532
Abstract
Background. Purpura fulminans (PF) – is an acute rapidly progressive thrombosis of small-diameter blood vessels located mainly on the skin of the extremities. PF is characterized by high mortality rates. Patients can have serious consequences, including amputations and loss of fingers, foots or even extremities in general.
Clinical case description. A clinical case of developing transient deficiency of protein S complicated by idiopathic PF on the 7th day after acute otitis in a 3-year-old boy due to past infection is presented. The progression of the disease developed within a few hours. The patient became hemorrhagic elements on the skin of extremities, and later — tissue necrosis. The conducted therapy facilitated to stop the pathological process in the form of PF, and also prevented the development of severe disabling complications in the child.
Conclusion. Differential diagnosis and treatment should be fast and accurate, as the development of PF occurs in mere hours. Diagnostics should include expanded panel of coagulological tests and instrumental examinations, which determines the justifiability of a multidisciplinary approach in the patient management with disorders in the hemostatic system.
About the Authors
Olga B. Gordeeva
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery;
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest:
Russian Federation
MD, PhD,
10, Fotievoy street, Moscow, 119333
Disclosure of interest:
Not declared.
Albina V. Dobrotok
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery
Russian Federation
Disclosure of interest:
Russian Federation
MD,
Disclosure of interest:
Not declared.
Liliia R. Selimzianova
Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery;
Pirogov Russian National Research Medical University;
Sechenov First Moscow State Medical University
Russian Federation
Disclosure of interest:
Russian Federation
Liliya R. Selimzyanova, MD, PhD,
Moscow
Disclosure of interest:
Not declared.
Valeria A. Deeva
Pirogov Russian National Research Medical University
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared.
References
1. Suvorova AV., Dorokhov NA, Malyuga OM. Purpura fulminans: possibilities of diagnostics and effective therapy. Thrombosis, hemostasis and rheology. 2013;(4):70. (In Russ).
2. Levin M, Eley B, Faust SN, et al. Lightning purple. In: Harper’s Textbook on Pediatric Dermatology. Hoeger P, Kinsler V, Yan A, et al., eds. John Wiley & Sons Ltd.; 2020. doi: https://doi.org/10.1002/9781119142812.ch146
3. Uttam KG. Purpura Fulminans. The Child and Newborn. 2020;24(1-2):30–32.
4. Ten Kate MK, Van Der Meer J. Protein S deficiency: a clinical perspective. Haemophilia. 2008;14(6):1222–1228. https://doi.org/10.1111/j.1365-2516.2008.01775.x
5. Thompson JJ, Ritter A, Hunt BJ. Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency. Blood Clotting and Fibrinolysis. 2010;21(6):598–600. doi: https://doi.org/10.1097/mbc.0b013e32833c2b52
6. Colling ME, Bendapudi PK. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis. Transfusion Medicine Reviews. 2018;32(2):69–76. doi: https://doi.org/10.1016/j.tmrv.2017.10.001
7. Koltunov IE, Keshishyan RA, Petrov MA, et al. Surgical treatment of wound defects in fulminant purpura. Wounds and wound infections. The Prof. B.M. Kostyuchenok Journal. 2017;4(2):24–33. (In Russ). doi: https://doi.org/10.25199/2408-9613-2017-4-2-24-3
8. Kazandjieva J, Antonov D, Kamarashev J, Tsankov N. Acrally distributed dermatoses: Vascular dermatoses (purpura and vasculitis). Clin Dermatol. 2017;35(1):68–80. doi: https://doi.org/10.1016/j.clindermatol.2016.09.013
9. Samman K, Le CK, Michon B. An atypical case of idiopathic lightning purpura. J Pediatr Hematol Oncol. 2022;44(8):479–481. doi: https://doi.org/10.1097/MPH.0000000000002497
10. Sirotkina OV, Ulitina AS, Kolegova MV, et al. Risks of thrombosis: genotype and phenotype of blood coagulation factor V. Russian Journal for Personalized Medicine. 2022;2(1):35–42. (In Russ). doi: https://doi.org/10.18705/2782-3806-2022-2-1-35-42
11. Gordeeva OB, Vashakmadze ND, Karaseva MS, et al. Modern Aspects of Anticoagulation System Disorders Diagnosis in Children with Different Polymorphisms in Coagulation Genes. Initial Results. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2022;19(4):326–335. (In Russ). doi: https://doi.org/10.15690/pf.v19i4.2444
12. Podsvirova EV, Balakireva EA, Romanova TA, et al. Case of early diagnosis of hereditary thrombophilia in a 16 days child. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2019;64:(3):82–86. (In Russ). doi: https://doi.org/10.21508/1027-4065-2019-64-3-82-86
Review
For citations:
Gordeeva O.B., Dobrotok A.V., Selimzianova L.R., Deeva V.A. Transient deficiency of protein S after past infection process, complications and outcome: clinical case. Pediatric pharmacology. 2023;20(1):69-76. (In Russ.) https://doi.org/10.15690/pf.v20i1.2532
Views:
1330
Email this article 